Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Bunclark (Cambridge (Cambridgeshire), United Kingdom), N. Doughty (Cambridge (Cambridgeshire), United Kingdom), A. Michael (Cambridge (Cambridgeshire), United Kingdom), N. Abraham (Cambridge (Cambridgeshire), United Kingdom), S. Ali (Cambridge (Cambridgeshire), United Kingdom), J. Cannon (Cambridge (Cambridgeshire), United Kingdom), K. Sheares (Cambridge (Cambridgeshire), United Kingdom), N. Speed (Cambridge (Cambridgeshire), United Kingdom), D. Taboada (Cambridge (Cambridgeshire), United Kingdom), M. Toshner (Cambridge (Cambridgeshire), United Kingdom), J. Pepke-Zaba (Cambridge (Cambridgeshire), United Kingdom). A Minimal Clinically Important Difference for CAMPHOR in Idiopathic Pulmonary Arterial Hypertension. 1517

Member's Comments

No comment yet.

Related content which might interest you: Clinical Features of Pulmonary Hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 CT Based Arterial and Venous Morphologic Changes In Pulmonary Hypertension Associated with COPD Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Red Blood Cell Distribution Width as a potential predictor of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Pulmonary Hypertension Source: Eur Respir Rev 2009; 18: 193-194 Year: 2009 Pulmonary Hypertension Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013 Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019 Characterize Idiopathic Pulmonary Fibrosis using Respiratory Oscillometry Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Postoperative Pulmonary Complications in Bronchial Asthma/Chronic Obstructive Pulmonary Disease/Non-Pulmonary Disease Patients Source: International Congress 2018 – Functional assessment of COPD Year: 2018 Poor Subpleural Perfusion as a predictor of Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Microvascular Endothelial Function in treated Pulmonary Arterial Hypertension Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis? Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020